According to a recent report by Emergent Research, the global Biophotonics Market is expected to reach USD 118.89 billion by 2027. The advancement of optical technologies increased research by researchers, and rising demand for early diagnosis are expected to drive market growth over the forecasted period. Biophotonics, an active research project, has many applications because of its ability to harness light weight for understanding the functioning of cells and tissue in living organisms. This aids in the more accurate diagnosis of health issues.
Biophotonics is the science of creating and utilizing light to visualize, detect, and modify biological components. It makes use of light and other forms of radiant energy to study the internal workings of cells and tissues in living organisms. In biology, biophotonics is used to investigate molecular processes, functions, and structures. It is used in medicine to investigate light-tissue interactions at the micro, nano, and macro-organism levels to detect, diagnose, and treat diseases.
According to the report’s scope, biophotonics is an emerging interdisciplinary research area that deals with all light-based technologies that are widely used in the life sciences and medicine. This report provides a detailed analysis of the biophotonics market technologies available in various regions around the world. The market is divided into two sections: technology (surface imaging, inside imaging, see-through imaging, microscopy, biosensors, medical lasers, spectromolecular imaging, and other technologies), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).
Some Key Highlights from the Report
The non-medical end-use phase is expected to be the fastest growing over the next few years. The escalating demand for non-medical applications is expected to provide numerous growth opportunities in the coming years. The ability of biophotonics to examine tissues at macro and micro scales and effectively diagnose diseases is expected to be a key reason for its engaging use in applications.
The use of nanotechnology in imaging biological processes and analyzing biological materials is increasing. The perfect measure used in medical specialty imaging is squared by gold and iron nanoparticles. For example, researchers from the University of Rochester used a gold nanoparticle as an antenna on the tip of AN fiber to boost the visible light of labeled proteins within the semipermeable membrane.
In addition to the current state, the market is expected to expand due to the increased adoption of technology in a variety of industries such as medicine, biotechnology, agriculture, nosology, and R&D in life sciences. Environmental monitoring, dosimetry, food analysis, medical imaging, and dentistry are examples of impact rendering applications that use scrutiny and Raman spectrometry.
Among the market’s key players are Andor Technology Ltd., Becton, Dickinson and Company, FEI Company, Lumenis Ltd., Zecotek Photonics Inc., Carl Zeiss AG, Hamamatsu Photonics K.K., and Affymetrix, Inc.
For this report, Emergen Research has segmented the global Biophotonics Market based on technology, application, end-user, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
- In-vivo
- In-vitro
Application Outlook (Revenue, USD Billion; 2017-2027)
- Endoscopy
- Spectromolecular
- Surface Imaging
- Microscopy
- Light Therapy
- Biosensors
End User Outlook (Revenue, USD Billion; 2017-2027)
-
- Medical Diagnostics
- Medical Therapeutics
- Test Components
Regional Outlook (Revenue: USD Billion; 2017-2027)
- North America
- the U.S.
- Canada
- Mexico
- Europe
- the UK
- Germany
- France
- BENELUX
- Rest of Europe
- the Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
